Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Instead of waiting for problems to occur and then treating them, 2025's innovations are all about prevention and early ...

GLP-1 receptor agonist labels in the U.S. (although not ... Study strengths include the large sample, restriction to new GLP-1 users and results that were robust in multiple sensitivity analyses.

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you ...

While older anti-obesity drugs may lead to less weight loss than semaglutide and tirzepatide, they remain useful tools in ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

The California Horse Racing Board's website reports that Quarter Horse trainer Monty Arrossa's trainees have returned four ...